Stocklytics Platform
Asset logo for symbol COYA
Coya Therapeutics
COYA51
$6.01arrow_drop_down0.82%-$0.05
Asset logo for symbol COYA
COYA51

$6.01

arrow_drop_down0.82%

Income Statement (COYA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$3.23M-$5.45M$2.00M-$3.56M-$3.25M
EBITDA-$3.22M-$5.45M$2.01M-$3.55M-$3.24M
gross Profit$3.41M$119.99K$5.99M-$6,841.00-$6,840.00
NET Income-$2.89M-$5.05M$1.26M-$3.42M-$3.09M
total Revenue$3.42M$126.83K$6.00M$0.00$0.00

Balance Sheet (COYA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$36.57M-$35.98M-$32.62M-$10.88M-$13.10M
stockholders Equity$35.25M$32.54M$35.64M$10.08M$13.24M
total Assets$39.93M$37.54M$41.27M$11.89M$14.46M
total Debt-----
total Liabilities$4.68M$5.00M$5.62M$1.80M$1.22M

Cash Flow (COYA)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$5.14M$1.24M$24.17M$0.00$0.00
free Cash Flow-$4.56M$2.12M-$2.24M-$2.21M-$2.86M
investing Cash Flow-----$350.00K
operating Cash Flow-$4.56M$2.14M-$2.24M-$2.21M-$2.86M

Coya Therapeutics (COYA) Financials

COYA Therapeutics, Inc. (COYA) is a biotechnology company focused on developing innovative therapies for various diseases. The company's financials are an important aspect of assessing its performance and growth potential. The income statement provides a summary of COYA's revenues, expenses, and net income. It shows how much money the company generated from its operations and how it utilized those funds. The EBIT (Earnings Before Interest and Taxes) is a measure of COYA's operating profitability, excluding the impact of interest and taxes. It gives investors an idea of the company's ability to generate profits from its core operations. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is another profitability metric that provides a clearer picture of COYA's operating performance by eliminating the effects of non-cash expenses. Gross profit represents the revenue remaining after deducting the cost of goods sold. It indicates the company's ability to generate sales at a profitable margin.
Net income from stockholders reflects the final profitability after all expenses, taxes, and interest payments have been accounted for. It represents the amount of money available to be distributed to stockholders or reinvested in the business. Total revenue encompasses all the money earned by COYA from its operations, including sales of products or services. The balance sheet provides a snapshot of COYA's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. Cash equivalents are highly liquid assets that can be easily converted into cash. They help ensure COYA's ability to meet its short-term obligations. Net debt is the difference between a company's total debt and its cash and cash equivalents. Stockholders' equity represents the residual interest in the assets of the company after deducting liabilities. It is an important measure of COYA's financial health. Total assets are the sum of all tangible and intangible assets that COYA owns. Total debt includes all financial obligations that COYA has, including both short-term and long-term liabilities. Total liabilities encompass all the financial obligations that COYA has, including both current and long-term liabilities.
Cash flow refers to the movement of cash into and out of COYA's business. It is a crucial indicator of the company's ability to generate cash and its financial flexibility. Financing cash flow represents the cash flow resulting from COYA's financing activities, such as issuing or repurchasing stock, paying dividends, or obtaining or repaying debt. Free cash flow is the cash generated by COYA's operations after deducting capital expenditures. It is an important measure of the company's ability to generate excess cash for growth and debt reduction. Investing cash flow represents the cash flow resulting from COYA's investing activities, such as acquiring or disposing of assets. Operating cash flow represents the cash flow resulting from COYA's core business operations, excluding financing and investing activities. It shows how well the company generates cash from its operations.
add Coya Therapeutics to watchlist

Keep an eye on Coya Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media